.webp)
The high-potency API (HPAPI) CDMO market is accelerating as pharmaceutical companies focus on oncology, hormonal therapies, and niche drugs, driving demand for specialized manufacturing expertise. The high-potency API (HPAPI) CDMO market is a rapidly growing segment within the pharmaceutical industry, driven by increasing demand for specialized drug manufacturing services. With a strong projected growth trajectory, this market is expected to expand significantly over the coming decade, reflecting its vital role in advanced medical therapies.
The global liquid nefopam hydrochloride market growth is influenced by research in safer analgesic therapies and rising surgical procedures. The market is growing due to increasing demand for convenient, fast-acting, and easily administrable pain relief formulations.
The global aseptic fill-finish manufacturing market size accounted for USD 5.95 billion in 2024 and is predicted to increase from USD 6.48 billion in 2025 to approximately USD 14.01 billion by 2034, expanding at a CAGR of 8.94% from 2025 to 2034.
The global scalp micropigmentation services market size accounted for USD 2.63 billion in 2024 and is predicted to increase from USD 2.80 billion in 2025 to approximately USD 4.88 billion by 2034, expanding at a CAGR of 6.37% from 2025 to 2034. The market for scalp micropigmentation services has experienced significant growth and is expected to continue expanding over the coming years.
The global pressure guidewires market size accounted for USD 573.48 million in 2024 and is predicted to increase from USD 621.86 million in 2025 to approximately USD 1,293.34 million by 2034, expanding at a CAGR of 8.48% from 2025 to 2034. It plays a crucial role in industries where safe and precise operations are essential, such as oil and gas, chemical processing, pharmaceuticals, and manufacturing.
The global fractional flow reserve market size was calculated at USD 0.97 billion in 2024 and is predicted to increase from USD 1.06 billion in 2025 to approximately USD 2.37 billion by 2034, expanding at a CAGR of 9.34% from 2025 to 2034. The market growth is attributed to increased risk of cardiovascular diseases due to lifestyle and dietary factors, increasing demand for evidence-based diagnostics, and rapid adoption of AI-driven imaging technologies.
The next-generation RNA therapeutics market is poised for strong growth as mRNA, siRNA, and antisense technologies enable innovative therapies for complex and previously untreatable diseases. The market growth is attributed to rising institutional funding and expanding applications of RNA platforms in oncology, rare genetic disorders, and infectious disease therapeutics.
The global real-time location systems market size was calculated at USD 5.23 billion in 2024 and is predicted to increase from USD 6.49 billion in 2025 to approximately USD 45.13 billion by 2034, expanding at a CAGR of 24.05% from 2025 to 2034. The market is driven by rapid urbanization, rising need for advanced security systems, rising use of smartphones and mobile gaming, and rapid growth in adoption in the healthcare segment.
The global myopia treatment devices market size accounted for USD 18.07 billion in 2024 and is predicted to increase from USD 19.49 billion in 2025 to approximately USD 38.51 billion by 2034, expanding at a CAGR of 7.86% from 2025 to 2034. This market is growing due to the rising prevalence of vision disorders among younger populations and the increasing adoption of advanced corrective technologies.
The psoriatic arthritis therapeutics drugs market is evolving rapidly with innovation in biosimilars, small molecules, and personalized medicine improving treatment outcomes. The market growth is attributed to rising psoriatic arthritis prevalence, expanding access to biologics and targeted oral therapies, and supportive regulatory approvals enhancing treatment adoption.
The global hyaluronic acid personal care products market size was estimated at USD 3.61 billion in 2024 and is predicted to increase from USD 3.92 billion in 2025 to approximately USD 8.34 billion by 2034, expanding at a CAGR of 8.74% from 2025 to 2034. The market for hyaluronic acid personal care products has experienced a massive spike in growth during recent years, reflecting increasing consumer awareness and demand for skincare and beauty products containing this popular ingredient. As we look to the future, the market is expected to continue its expansion, driven by innovations and expanding applications across the personal care industry.
The global flexible electronics in healthcare market size accounted for USD 7.00 billion in 2024 and is predicted to increase from USD 8.40 billion in 2025 to approximately USD 43.57 billion by 2034, expanding at a CAGR of 20.70% from 2025 to 2034. The rising prevalence of chronic diseases, growing demand for wearable health monitors, increasing consumer preference for biosensor-equipped smart clothing, and rapid technological innovation are expected to boost the growth of the global flexible electronics in healthcare market over the forecast period. Several prominent players are widely adopting effective strategies like new product launches and mergers to gain a competitive edge and strengthen their market share. Additionally, the market is expanding in emerging regions, particularly the Asia Pacific, fueled by the presence of key market players and the expansion of production & manufacturing capacity of flexible electronics.
The global glycyrrhiza glabra licorice root extract market size accounted for USD 2.15 billion in 2024 and is predicted to increase from USD 2.28 billion in 2025 to approximately USD 3.87 billion by 2034, expanding at a CAGR of 6.05% from 2025 to 2034. The market is experiencing significant growth due to the increasing demand for herbal and natural ingredients in pharmaceuticals, cosmetics, and food products. This growth is further supported by the anti-inflammatory, antioxidant, and antimicrobial properties of these ingredients. Additionally, the rising use of herbal products in skincare, respiratory health supplements, and functional foods is expected to drive market expansion.
The global vitamin B-complex ingredients market size accounted for USD 3.35 billion in 2024 and is predicted to increase from USD 3.49 billion in 2025 to approximately USD 5.01 billion by 2034, expanding at a CAGR of 4.11% from 2025 to 2034. Increasing awareness about vitamin B complex and its crucial functions in the body, prevalence of diseases due to low immunity, vitamin deficiency, and innovative healthcare product launches by several key players in the market are driving factors for the market.
The global reusable laparoscopic instruments market size accounted for USD 3.27 billion in 2024 and is predicted to increase from USD 3.49 billion in 2025 to approximately USD 6.28 billion by 2034, expanding at a CAGR of 6.74% from 2025 to 2034. The market is driven by the rising demand for minimally invasive surgeries, the increasing prevalence of chronic diseases, and the cost-effectiveness of reusable laparoscopic instruments.
The global rifaximin market size accounted for USD 1.84 billion in 2024 and is predicted to increase from USD 2.04 billion in 2025 to approximately USD 5.09 billion by 2034, expanding at a CAGR of 10.72% from 2025 to 2034. The increased awareness about effective treatment options for gastrointestinal disease and demand for non-systemic antibiotics, like rifaximin driving the market.
The global non-sterile liquids and suspensions market size accounted for USD 48.06 million in 2024 and is predicted to increase from USD 51.46 million in 2025 to approximately USD 95.25 million by 2034, expanding at a CAGR of 7.08% from 2025 to 2034. The market for non-sterile liquids and suspensions is driven by rising demand for oral medications, ease of administration, pediatric and geriatric preference, cost-effectiveness, expanding pharmaceutical production, and increasing prevalence of chronic diseases.
The global pulmonary alveolar proteinosis (PAP) drugs market size was estimated at USD 750.05 million in 2024 and is predicted to increase from USD 802.70 million in 2025 to approximately USD 1,478.22 million by 2034, expanding at a CAGR of 7.02% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of rare lung disorders and a heightened focus on targeted therapies. This growth is further supported by advancements in biologics and the development of both inhaled and systemic treatment options. Additionally, an increase in clinical research and orphan drug designations is expected to further accelerate market expansion.
The global nefopam hydrochloride injection market size accounted for USD 120.06 billion in 2024 and is predicted to increase from USD 129 billion in 2025 to approximately USD 246.30 billion by 2034, expanding at a CAGR of 7.45% from 2025 to 2034. The increased demand for non-opioid analgesics is driving the adoption of nefopam hydrochloride injections, leading to an expansion of the market acceptability and availability. Additionally, the ongoing advancements in drug delivery systems are further contributing to the increasing adoption of nefopam hydrochloride injections globally, particularly in Europe, the Asia Pacific, and Latin America.
The global patient telemonitoring systems market is shaped by regulatory support and technological advancements in wearable and connected health devices.The growing rate of chronic diseases globally, technological advancements like AI/ML and its integration into healthcare systems, increasing shift to online consulting are driving factors of the patient telemonitoring systems market.
The global laser-based 3D bioprinting market size was calculated at USD 1.54 billion in 2024 and is predicted to increase from USD 1.79 billion in 2025 to approximately USD 7.11 billion by 2034, expanding at a CAGR of 16.53% from 2025 to 2034. The rapid growth of the laser-based 3D bioprinting market is driven by growing need for organ and tissue regeneration, pharmaceutical drug testing, and ongoing improvements in laser precision and biocompatible materials.
The global penicillin G acylase market size accounted for USD 150.05 million in 2024 and is predicted to increase from USD 158.39 million in 2025 to approximately USD 257.77 million by 2034, expanding at a CAGR of 5.56% from 2025 to 2034. The growing demand for semi-synthetic antibiotics, rapid advancements in enzyme immobilization technologies, growing demand for enzyme-based manufacturing processes, and increasing popularity of sustainable production methods are expected to drive the growth of the global market for penicillin G acylase over the forecast period. Several key players in the market are widely adopting effective strategies to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by increasing healthcare expenditure and a surge in research activities.
The global cardiotoxicity screening market size accounted for USD 2.84 billion in 2024 and is predicted to increase from USD 3.17 billion in 2025 to approximately USD 8.46 billion by 2034, expanding at a CAGR of 11.54% from 2025 to 2034. The increased demand for effective and precise cardiotoxicity screening methods is driving the global market. The growing awareness about drug safety is further contributing to this demand.
The global ceftazidime-avibactam market size accounted for USD 3.3 billion in 2024 and is predicted to increase from USD 3.56 billion in 2025 to approximately USD 7.15 billion by 2034, expanding at a CAGR of 8.05% from 2025 to 2034. The market for ceftazidime-avibactam is experiencing substantial growth due to the rising incidence of multidrug-resistant gram-negative infections, which is driving its demand in clinical settings. This demand is further reinforced by its effectiveness in treating complicated intra-abdominal and urinary tract infections. Increasing hospital utilization and heightened awareness of antimicrobial resistance are expected to accelerate market expansion.
The global cables for endoscopes market size accounted for USD 1.26 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.00 billion by 2034, expanding at a CAGR of 9.06% from 2025 to 2034. The market is showing steady growth with the developments in imaging technology used in the medical field, growing demand for minimally invasive surgery, and spending growth in healthcare and healthcare infrastructure, indicating an overall positive prognosis for the market.
The global biopsy bag market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.11 billion by 2034, expanding at a CAGR of 9.54% from 2025 to 2034. The market is driven by rising cancer prevalence, increasing biopsy procedures, and growing demand for safe and contamination-free specimen handling.
The global pentoxifylline drug market size accounted for USD 450.06 million in 2024 and is predicted to increase from USD 479.49 million in 2025 to approximately USD 848.00 million by 2034, expanding at a CAGR of 6.54% from 2025 to 2034. The market is experiencing substantial growth due to the increasing prevalence of peripheral artery diseases and chronic blood circulation disorders. This demand is further supported by pentoxifylline’s effectiveness in improving blood flow and alleviating the symptoms of vascular conditions. Additionally, its growing relevance in managing diabetic neuropathy and other microcirculatory complications is expected to drive market expansion.
The global intellectual and development disability care market size was estimated at USD 24.60 billion in 2024 and is predicted to increase from USD 26.29 billion in 2025 to approximately USD 47.72 billion by 2034, expanding at a CAGR of 6.85% from 2025 to 2034. The market is growing steadily as healthcare systems place a greater emphasis on inclusivity, personalized care, and long-term support services.
The global fibromyalgia treatment market size was calculated at USD 3.49 billion in 2024 and is predicted to increase from USD 3.63 billion in 2025 to approximately USD 5.16 billion by 2034, expanding at a CAGR of 3.97% from 2025 to 2034. The growing adoption of combination therapies, biologics, and personalized medicine approaches enhances treatment outcomes, driving the market’s growth in emerging nations. The three drugs that are FDA-approved specifically for fibromyalgia include pregabalin (Lyrica), duloxetine (Cymbalta), and milnacipran (Savella). Additionally, North America dominated the market, fuelled by the high healthcare expenditure and accessibility of advanced treatments.
The global electrolyte tablet market size accounted for USD 5.12 billion in 2024 and is predicted to increase from USD 5.38 billion in 2025 to approximately USD 8.33 billion by 2034, expanding at a CAGR of 4.99% from 2025 to 2034. The electrolyte tablet market is experiencing significant growth, with its size expected to increase substantially in the coming years. Driven by rising health consciousness and hydration needs, it is projected to expand rapidly.
The global soybean oil pharma grade market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.34 billion in 2025 to approximately USD 2.54 billion by 2034, expanding at a CAGR of 7.34% from 2025 to 2034. The market is driven by rising demand for natural excipients in drug formulations and growing use in nutraceuticals and soft gel capsules.
The global nigella sativa extract market size accounted for USD 1.7 billion in 2024 and is predicted to increase from USD 1.88 billion in 2025 to approximately USD 4.59 billion by 2034, expanding at a CAGR of 10.45% from 2025 to 2034. The market is expanding due to growing awareness of Nigella sativa extracts and their potential medicinal properties, ongoing research that shows its efficiency, and a strong supply chain.
The global multi-chamber bags for parenteral nutrition market size accounted for USD 1.55 billion in 2024 and is predicted to increase from USD 1.67 billion in 2025 to approximately USD 3.21 billion by 2034, expanding at a CAGR of 7.54% from 2025 to 2034. The market is growing due to increasing incidence of chronic diseases and gastrointestinal conditions, advances in safer, more user-friendly bag design, and the enhancement of home-based, nutritional care, clearly upward.
The global dunaliella salina extract market size accounted for USD 200.06 million in 2024 and is predicted to increase from USD 217.27 million in 2025 to approximately USD 456.52 million by 2034, expanding at a CAGR of 8.60% from 2025 to 2034. The market is experiencing significant growth due to the rising demand for natural antioxidants and carotenoids in nutraceuticals and cosmetics. This demand is supported by the high beta-carotene content of the extract and its associated health benefits in skincare and dietary supplements. Additionally, the increasing use of personal food products and anti-aging treatments is expected to further boost market expansion.
The global cranberry capsules market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.36 billion in 2025 to approximately USD 2.94 billion by 2034, expanding at a CAGR of 8.94% from 2025 to 2034. The market is growing due to rising consumer awareness of its benefits in supporting urinary tract health and overall wellness.
The Asia Pacific pain relief oil market size was calculated at USD 1.36 million in 2024 and is predicted to increase from USD 1.45 million in 2025 to approximately USD 2.46 million by 2034, expanding at a CAGR of 6.11% from 2025 to 2034. The pain relief oil market is a rapidly growing sector within the healthcare industry, driven by increasing demand for natural and effective pain management solutions.
The global gastroparesis treatment market size accounted for USD 6.63 billion in 2024 and is predicted to increase from USD 6.94 billion in 2025 to approximately USD 10.45 billion by 2034, expanding at a CAGR of 4.65% from 2025 to 2034. The market is steadily growing, driven by the rising prevalence of diabetes-related gastric dysfunction, a growing need for minimally invasive devices and new prokinetics, and increased awareness, suggesting the market is on a path for a sustainable, upward trend.
The global fibroblast growth factors (FGFs) market size accounted for USD 3.54 billion in 2024 and is predicted to increase from USD 3.84 billion in 2025 to approximately USD 8.03 billion by 2034, expanding at a CAGR of 8.54% from 2025 to 2034. The market is experiencing significant growth, driven by increasing research in regenerative medicine and tissue repair. This growth is further supported by expanding applications in wound healing, stem cell therapy, and cancer research. Additionally, advancements in biologics and an increase in clinical studies are anticipated to accelerate market expansion.
The global prostaglandin analogs market size accounted for USD 3.54 billion in 2024 and is predicted to increase from USD 3.75 billion in 2025 to approximately USD 6.38 billion by 2034, expanding at a CAGR of 6.06% from 2025 to 2034. The market growth is attributed to the rising glaucoma prevalence and increasing adoption of early treatment protocols supported by global health initiatives.
The global epidermal growth factors (EGFs) market size accounted for USD 1.19 billion in 2024 and is predicted to increase from USD 1.24 billion in 2025 to approximately USD 1.72 billion by 2034, expanding at a CAGR of 3.75% from 2025 to 2034. The increased demand for advanced skincare products, wound healing treatments, and regenerative medicines is driving the global market. The growing innovations in personalized skincare solutions are further contributing to the market growth. The increased demand for advanced skincare products.
The global eliquis market size accounted for USD 20.15 billion in 2024 and is predicted to increase from USD 21.09 billion in 2025 to approximately USD 31.74 billion by 2034, expanding at a CAGR of 4.65% from 2025 to 2034. The market is significantly expanding due to increasing incidences of fatal illnesses like CVDs, cancer, which can be treated effectively by the Eliquis molecule, which is supported by regulatory bodies as well.
The U.S. pantoprazole market size was estimated at USD 743.96 million in 2024 and is predicted to increase from USD 785.46 million in 2025 to approximately USD 1,302.87 million by 2034, expanding at a CAGR of 5.76% from 2025 to 2034. The market is growing due to rising cases of gastroesophageal reflux disease (GERD) and other acid-related disorders worldwide.
The global long-acting injectables (LAIs) market size accounted for USD 16.94 billion in 2024 and is predicted to increase from USD 19.14 billion in 2025 to approximately USD 57.26 billion by 2034, expanding at a CAGR of 12.95% from 2025 to 2034. The market is gaining traction due to improved adherence, reduced dosing frequency, and providing stable pharmacokinetics for chronic and specialty conditions. Also, an obvious reason for this rise is the advancement in drug delivery systems.
The global baby swabs market size was calculated at USD 1.31 billion in 2024 and is predicted to increase from USD 1.43 billion in 2025 to approximately USD 3.19 billion by 2034, expanding at a CAGR of 9.32% from 2025 to 2034. The heightened parental awareness of hygiene, demand for eco-friendly materials, and the convenience of usage are expected to drive the growth of the global baby swabs market over the forecast period. Several key players in the market are increasingly adopting various strategies to boost the sales of baby cotton swabs, such as mergers, acquisitions, and new product launches, to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by the presence of key market players and growing demand for hygiene products.
The global smart fall detection device market size was calculated at USD 1.25 billion in 2024 and is predicted to increase from USD 1.41 billion in 2025 to approximately USD 4.18 billion by 2034, expanding at a CAGR of 12.83% from 2025 to 2034. The market is significantly fuelling due to an increasing ageing population who need continues monitoring and postoperative care, advancement in sensor technology like IoT, AI/ML integration with fall detection devices, and enhanced awareness about preventive measures in the healthcare sector.
The global pantoprazole market size was estimated at USD 2.51 billion in 2024 and is predicted to increase from USD 2.65 billion in 2025 to approximately USD 4.34 billion by 2034, expanding at a CAGR of 5.64% from 2025 to 2034. The rising prevalence of gastroesophageal reflux disease (GERD), increasing regulatory approvals, and rapid advancements in drug delivery systems are expected to drive the growth of the global pantoprazole market over the forecast period. Several key players in the industry are widely adopting effective strategies like new product launches and mergers to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by the presence of key market players and rising increasing prevalence of gastroesophageal reflux disease (GERD).
The global diabetes nutrition market size accounted for USD 12.64 billion in 2024 and is predicted to increase from USD 13.54 billion in 2025 to approximately USD 25.22 billion by 2034, expanding at a CAGR of 7.15% from 2025 to 2034. The market is on the rise due to the increase of diabetes worldwide, the global population is aging, and urbanization and demand for dietary products designed for consumers with diabetes, ranging from low-sugar to low-carbohydrate.
The global glucosamine market size accounted for USD 1.10 billion in 2024 and is predicted to increase from USD 1.16 billion in 2025 to approximately USD 1.90 billion by 2034, expanding at a CAGR of 5.63% from 2025 to 2034. The market growth is attributed to increasing consumer awareness of joint health and the rising adoption of preventive healthcare practices globally.
The global HT supplement (50X) market size was calculated at USD 1.85 billion in 2024 and is predicted to increase from USD 2.02 billion in 2025 to approximately USD 4.55 billion by 2034, expanding at a CAGR of 9.42% from 2025 to 2034. The market for HT supplement is growing due to increased interest in biotechnology research and the prior use of cellular science, cell culture, and protein expression, and increased funding in the life sciences sector research, clearly being an area of high growth, use, and demand.
The global adult clinical nutrition market size was estimated at USD 21.56 billion in 2024 and is predicted to increase from USD 22.62 billion in 2025 to approximately USD 34.82 billion by 2034, expanding at a CAGR of 4.91% from 2025 to 2034. The adult clinical nutrition market is experiencing growth due to the aging population, the rising prevalence of chronic diseases, and greater awareness of specialized nutritional needs.
